14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of FENC
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Fennec Pharmaceuticals, Inc stock price ended at $9.07 on Wednesday, after losing 1.84%.
(Updated on Apr 24, 2024)

Sell candidate since Apr 15, 2024 Loss -12.20% PDF

The Fennec Pharmaceuticals, Inc stock price fell by -1.84% on the last day (Wednesday, 24th Apr 2024) from $9.24 to $9.07. During the last trading day the stock fluctuated 3.79% from a day low at $8.96 to a day high of $9.30. The price has fallen in 8 of the last 10 days and is down by -15% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -107 thousand shares and in total, 181 thousand shares were bought and sold for approximately $1.65 million.

The stock has broken the wide and weak rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $9.38. A reaction back to this level may hold a second chance to get out before further falls.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

FENC Signals & Forecast

There are few to no technical positive signals at the moment. The Fennec Pharmaceuticals, Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $9.51 and $10.34. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, March 28, 2024, and so far it has fallen -18.44%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Fennec Pharmaceuticals, Inc stock

Fennec Pharmaceuticals, Inc finds support from accumulated volume at $9.01 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.340 between high and low, or 3.79%. For the last week, the stock has had daily average volatility of 4.57%.

Fennec Pharmaceuticals, Inc is oversold on RSI14 (15). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (FENC) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Fennec Pharmaceuticals, Inc to open at $9.11, and during the day (based on 14 day Average True Range), to move between $8.62 and $9.52, which gives a possible trading interval of +/-$0.447 (+/-4.93%) up or down from last closing price. If Fennec Pharmaceuticals, Inc takes out the full calculated possible swing range there will be an estimated 9.85% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $9.01 (0.66%) than the resistance at $9.40 (3.64%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Fennec Pharmaceuticals, Inc stock A Buy?

The Fennec Pharmaceuticals, Inc stock holds several negative signals and despite the positive trend, we believe Fennec Pharmaceuticals, Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.116 Sell Candidate Unchanged

Predicted Opening Price for Fennec Pharmaceuticals, Inc of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$9.11 ( 0.441%) $9.07

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for FENC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.45 4.19 %
R2 9.32 2.76 %
R1 9.24 1.87 %
Current price: 9.07
Support S1 8.98 -0.99 %
S2 8.90 -1.88 %
S3 8.77 -3.31 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 11.07 22.05 %
R2 9.47 4.41 %
R1 9.40 3.64 %
Current price 9.07
Support S1 9.01 -0.662%
S2 9.00 -0.772%
S3 8.82 -2.76%

FAQ

What is the symbol for Fennec Pharmaceuticals, Inc Stock and on which exchange is it traded?
The symbol for Fennec Pharmaceuticals, Inc is FENC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Fennec Pharmaceuticals, Inc Stock?
The Fennec Pharmaceuticals, Inc stock holds several negative signals and despite the positive trend, we believe Fennec Pharmaceuticals, Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Fennec Pharmaceuticals, Inc Stock?
Fennec Pharmaceuticals, Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Fennec Pharmaceuticals, Inc Stock.

What's the current price of Fennec Pharmaceuticals, Inc Stock?
As of the end of day on the Apr 24, 2024, the price of an Fennec Pharmaceuticals, Inc (FENC) share was $9.07.

What is the 52-week high and low for Fennec Pharmaceuticals, Inc Stock?
The 52-week high for Fennec Pharmaceuticals, Inc Stock is $11.92 and the 52-week low is $6.30.

What is the market capitalization of Fennec Pharmaceuticals, Inc Stock?
As of the Apr 24, 2024, the market capitalization of Fennec Pharmaceuticals, Inc is 250.403M.

When is the next earnings date for Fennec Pharmaceuticals, Inc?
The upcoming earnings date for Fennec Pharmaceuticals, Inc is May 09, 2024.
Click to get the best stock tips daily for free!

About Fennec Pharmaceuticals, Inc

Fennec Pharmaceuticals Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is ba... FENC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT